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CASE REPORT
Asymptomatic tracheal MALT lymphoma 
discovered on spirometric findings presenting 
with elevated respiratory resistance
Naoki Kadota1, Tsutomu Shinohara2*, Hisanori Machida1, Hirofumi Nakanishi3, Fumie Suehiro3, Hiroko Toda4, 
Tadashi Yoshino4 and Fumitaka Ogushi1
Abstract 
Background: Central airway obstruction (CAO) may be caused by various etiologies. However, conventional chest 
X-rays are rarely diagnostic for patients with CAO.
Case presentation: We here described a 64-year-old asymptomatic female with tracheal mucosa-associated lym-
phoid tissue lymphoma discovered on spirometric findings during a complete physical examination. The plateau 
of forced expiratory flow was consistent with CAO. A decreased peak expiratory flow rate was noted at least 3 years 
before the diagnosis, and was attributed to an insufficient effort by the patient. Impulse oscillometric measurements, 
which were taken during quiet breathing and were effort-independent, suggested elevated respiratory resistance. 
These abnormalities completely disappeared after radiation therapy.
Conclusion: The addition of impulse oscillometry to spirometry may be useful for screening CAO in routine health 
examinations.
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Background
Central airway obstruction (CAO) in the trachea and/
or main bronchi may be caused by various etiologies, 
including a primary tumor, the formation of granulation 
tissue, inflammatory diseases, and foreign body aspira-
tion. Of these disorders, tracheal malignant lymphoma is 
extremely rare [1–3].
The clinical presentation and disease course of CAO 
differs according to the underlying etiology, location, and 
progression rate. In any case, conventional chest X-rays 
are rarely diagnostic for patients with CAO.
We here described a case of asymptomatic tracheal 
mucosa-associated lymphoid tissue (MALT) lymphoma 
discovered on spirometric findings during a complete 
physical examination that presented with elevated res-
piratory resistance, as analyzed by impulse oscillometry.
Case presentation
A 64-year-old female was referred to our hospital because 
of obstructive ventilatory impairment on spirometry 
(FEV1/FVC ratio = 36.95%, %VC = 109.3%), which was 
incidentally found during a complete physical examina-
tion. The pattern of a plateau in forced expiratory flow 
(FEF) suggested CAO (Figure 1b) [4].
No abnormalities were observed on a chest X-ray, 
whereas chest computed tomography revealed ante-
rior tracheal wall thickening (Figure 2a). The minor-axis 
of the airway was narrowed to approximately 9  mm, 
whereas the major-axis was 14  mm. An endoscopic 
examination revealed glossy polypoid tumors in the 
lower trachea (Figure  2b). The pathological findings of 
the tracheal mass indicated the diffuse infiltration of 
small- and medium-sized lymphocytes in the submu-
cosal lesions with the formation of lymphoid follicles 
(Figure 2c). The malignant cells were positive for CD20, 
but not for CD3 or CD5, which indicated a B cell ori-
gin. The MIB-1 index in the germinal center was high. 
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These findings established the diagnosis of endobronchial 
MALT lymphoma.
Retrospectively evaluated spirometric findings indi-
cated that a decreased peak expiratory flow rate (blunt-
ing in the flow–volume curve) with a normal FEV1/ 
FVC ratio (82.04%) and %VC (110%) had been recorded 
at least 3 years before the diagnosis (Figure 1a), and was 
attributed to an insufficient effort by the patient. Meas-
urements taken by impulse oscillometry (MostGraph-01; 
Chest M.I., Co. Ltd., Tokyo, Japan) [5, 6] suggested ele-
vated respiratory resistance (Rrs) (Figure  3a). The aver-
age difference between Rrs at 5 Hz (R5) and 20 Hz (R20) 
(0.24 cmH2O/L/s) and respiratory reactance (Xrs) at 5 Hz 
(X5) (−0.26 cmH2O/L/s) were small in this case.
Figure 1 Time-course of the flow–volume curve suggesting long-term intrathoracic CAO. a Decreased peak expiratory flow rate 3 years before the 
diagnosis. b A plateau in FEF accompanied by relatively preserved FIF at presentation. c Improvements observed during radiation therapy at doses 
of 24 Gy. d Improvements observed after radiation therapy (36 Gy).
Figure 2 CT (a, d), endoscopy (b, e), and pathology (c) images before (a–c) and after (d, e) radiation therapy. c H&E stain ×40; insert ×400.
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Narrowing of the trachea completely disappeared (Fig-
ure  2d, e) and obstructive ventilatory impairment nor-
malized (FEV1/FVC ratio = 85.66%, %VC = 109.8%) after 
radiation therapy at a total dose of 36 Gy. Abnormal find-
ings on the flow–volume curve resolved (Figure  1c, d) 
and Rrs also decreased (Figure 3b).
Discussion
The rareness of tracheal lymphoma may be ascribed to 
markedly less lymphoid tissue in the trachea than in the 
lung. MALT lymphoma commonly occurs after long-
term preexisting disorders, such as gastric Helicobacter 
pylori infection, salivary gland inflammation in Sjögren 
syndrome, and Hashimoto’s thyroiditis. However, anti-
genic stimulations that induce MALT lymphoma in the 
trachea have not been identified. MALT lymphoma tends 
to localize for a long time and responds to local treat-
ments including radiation therapy, which was selected in 
this case [7–11].
Exertional dyspnea and wheezing are the main symp-
toms of CAO. However, we need to be aware that clinical 
symptoms do not appear unless the trachea is narrowed 
to less than 8  mm [12–15]. Therefore, examining the 
flow–volume curve pattern in detail is crucial for detect-
ing CAO in asymptomatic patients. The particular flat-
tening in the flow–volume curve that implies CAO may 
exist previous to obstructive ventilatory impairments, as 
was found in this case.
Airway resistance (Raw) can be measured during body 
plethysmography, which is a well-established method 
for determining lung function using a large chamber 
(approximately 700–1,000 L). On the other hand, impulse 
oscillometry can easily evaluate Rrs and Xrs at various 
oscillometric frequencies without a chamber, which can-
not be achieved with body plethysmography. Although 
the frequency of the clinical use of impulse oscillometry 
appears to differ between countries, this test is covered 
by the national health insurance of Japan. Elevated Rrs 
Figure 3 3D images of Rrs analyzed by impulse oscillometry before (a) and after (b) radiation therapy.
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due to tracheal stenosis, as analyzed by impulse oscil-
lometry, was previously reported in patients who had a 
history of tracheostomies without current tracheostomy 
[16, 17]. Handa et  al. recently assessed CAO caused by 
various etiologies using impulse oscillometry and dem-
onstrated that the R5–R20 was markedly higher in sub-
jects with variable CAO (defined as a difference in the 
airway lumen diameter between inspiration and expi-
ration >50%) than in those with fixed CAO (differ-
ence <50%), with a threshold above 2.14  cmH2O/L/s 
(0.21 kPa/L/s). Furthermore, a significant difference was 
observed in X5 between variable and fixed CAO, with a 
threshold below −1.94  cmH2O/L/s (−0.19  kPa/L/s) [5]. 
The main reason for these findings was attributed to an 
upper airway shunt. The R5–R20 (0.24 cmH2O/L/s) and 
X5 (−0.26 cmH2O/L/s) in this case suggested fixed CAO, 
which is consistent with malignant disease [18].
Spirometry requires a maximal effort by the patient to 
achieve optimal results. Inadequately performed spirom-
etry can lead to a decreased peak expiratory flow rate and 
flow–volume curve similar to that in CAO, and it is diffi-
cult for non-specialist physicians to evaluate whether the 
spirometric test was performed based on the maximum 
effort of a patient. Therefore, a decreased peak expira-
tory flow rate with a normal FEV1/FVC ratio and %VC 
in this case was attributed to an insufficient effort by the 
patient. In contrast, impulse oscillometry is performed 
during quiet breathing and is effort-independent [19, 
20]. This technique may represent a promising alterna-
tive for evaluating lung mechanics in patients in whom 
the maneuvers involved in spirometry and body plethys-
mography are difficult to carry out [16, 17]. MostGraph is 
a newly-developed commercially available impulse oscil-
lometric method with color 3D imaging. Since the real-
time 3D display is understandable, as shown in this case, 
this technology may become useful as an auxiliary tool in 
the diagnosis of airway diseases, even for non-specialist 
physicians engaged in health check-ups. However, the 
clinical implications of measurements taken by impulse 
oscillometry are still being debated. Further studies are 
needed in order to establish standardized guidelines for 
and the reliability of impulse oscillometry.
Conclusion
The addition of impulse oscillometry to spirometry may 
be useful for screening CAO in routine health exami-
nations. Moreover, malignant tracheal tumors should 
be considered when an abnormal flow–volume curve is 
detected by spirometry, even in asymptomatic subjects.
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